Drugs / MeMuRu-OKA
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00352898 | Apr → Nov 2006 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00353288 | Mar → Nov 2006 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00351923 | Mar → Dec 2006 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MeMuRu-OKA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00351923 ↗ |
| Known as | MeMuRu-OKA Vaccine | “MeMuRu-OKA Vaccine” NCT00353288 ↗ |
| Modality | Vaccine | “MeMuRu-OKA vaccine” NCT00351923 ↗ |